Cite

HARVARD Citation

    Gupta, R. et al. (n.d.). 544PctDNA assays identify alterations in RAS, EGFR, and cMET that are unique to RAS-WT patients progressing on anti-EGFR therapy. Annals of oncology. p. . [Online]. 
  
Back to record